Key facts
- Rimsys’s last known valuation is $26.3M.
- It has raised $22.8M across 3 recorded rounds; the latest was Early Stage VC ($5.3M) in Mar 2024.
- Notable investors include Bessemer Venture Partners, Innovation Works, Ben Franklin Technology Partners of Southeastern Pennsylvania, Allos Ventures, BlueTree Allied Angels — 9 tracked in total.
- Rimsys has filed 4 Form Ds with the SEC since 2020, most recently Oct 2024 ($5.3M sold to 24 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Rimsys
Funding rounds
3 roundsAbout Rimsys
Developer of a cloud-based regulatory software designed to help medical device companies actively track the regulatory landscape. The company's software tracks product registrations by actively tracking technical files and monitoring standards in company management, enabling clients to change their business into a simple and structured place for the entire team and its international partners.
- Sector
- Healthcare
- HQ
- Pittsburgh, PA, United States
- Founded
- 2017
- Employees
- 33
- Website
- rimsys.io/
- Ownership
- Privately Held (backing)
Rimsys doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Rimsys shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Rimsys in its N-PORT filings yet. We sweep new filings monthly.